Related references
Note: Only part of the references are listed.Pharmacokinetics and Safety of Golimumab in Healthy Chinese Subjects Following a Single Subcutaneous Administration in a Randomized Phase I Trial
Yanli Zhuang et al.
CLINICAL DRUG INVESTIGATION (2013)
Lack of Racial Differences in the Pharmacokinetics of Subcutaneous Golimumab in Healthy Japanese and Caucasian Male Subjects
Jie Ling et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects
Zhenhua Xu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α
David Shealy et al.
MABS (2010)
Share Paper
